4//SEC Filing
Schneyer Mark C. 4
Accession 0001415889-25-022359
CIK 0001070494other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:00 PM ET
Size
5.4 KB
Accession
0001415889-25-022359
Insider Transaction Report
Form 4
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-08-18$25.18/sh−22,000$554,024→ 40,130 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001899977
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:00 PM ET
- Size
- 5.4 KB